Literature DB >> 33219803

Lack of Susceptibility to SARS-CoV-2 and MERS-CoV in Poultry.

David L Suarez, Mary J Pantin-Jackwood, David E Swayne, Scott A Lee, Suzanne M DeBlois, Erica Spackman.   

Abstract

We challenged chickens, turkeys, ducks, quail, and geese with severe acute respiratory syndrome coronavirus 2 or Middle East respiratory syndrome coronavirus. We observed no disease and detected no virus replication and no serum antibodies. We concluded that poultry are unlikely to serve a role in maintenance of either virus.

Entities:  

Keywords:  COVID-19; MERS-CoV; Middle East respiratory syndrome coronavirus; SARS; SARS-CoV-2; SARS-related coronavirus; chicken; coronavirus disease; duck; goose; mammalian beta-coronavirus; poultry; poultry health; quail; respiratory infections; severe acute respiratory syndrome; severe acute respiratory syndrome coronavirus 2; turkey; viruses; zoonoses

Mesh:

Substances:

Year:  2020        PMID: 33219803      PMCID: PMC7706925          DOI: 10.3201/eid2612.202989

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


Coronaviruses of animals periodically transmit to humans (), as recently occurred with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 was recognized in December 2019 in cases of atypical pneumonia in hospitalized patients in Wuhan, China. The virus is a novel betacoronavirus, related to the now-eradicated severe acute respiratory syndrome coronavirus (SARS-CoV) from 2003, with which SARS-CoV-2 has 82% identity across the genome (). SARS-CoV-2 is highly transmissible among humans and particularly virulent for elderly persons and those with certain underlying health conditions. Multiple studies have examined the susceptibility of domestic animals to SARS-CoV-2 to establish the risk for zoonotic transmission; 2 studies have shown chickens and Pekin ducks were not susceptible to infection (,). Middle East respiratory syndrome coronavirus (MERS-CoV), another coronavirus of high concern associated with zoonotic infection, was first detected in patients with severe acute lower respiratory tract disease in Saudi Arabia in 2012. MERS-CoV causes lower respiratory disease, similar to the SARS-CoVs (). Unlike SARS-CoV-2, MERS-CoV transmits poorly to humans and does not exhibit sustained human-to-human transmission; however, it has a high case fatality rate of »30%. Although the MERS-CoV case count is low, human cases continue to be reported, therefore there is a possibility for the virus to adapt to humans. Based on sequence similarity, the closest relatives of SARS-CoV-2 and MERS-CoV are believed to be bat betacoronaviruses (); the sequence difference between human and bat isolates suggests the existence of an intermediary host. For MERS-CoV, dromedary camels appear to be the primary natural reservoir of infection to humans, but other domestic animals seem to be susceptible to infection (,). Hemida et al. looked for MERS-CoV antibodies in chickens; all samples were negative (). Because poultry are so widespread and have close and extended contact with humans and other mammals in many production systems, including live animal markets, we conducted susceptibility studies with SARS-CoV-2 and MERS-CoV in 5 common poultry species. Embryonating chicken eggs (ECE) have been used for virus isolation culture, including use in vaccine production, for diverse avian and mammalian viruses; therefore, we tested ECE for their ability to support the replication of both viruses. We examined 5 poultry species: chickens (Gallus gallus domesticus), turkeys (Meleagris gallopavo), Pekin ducks (Anas platyrhinchos domesticus), Japanese quail (Coturnix japonica), and white Chinese geese (Anser cygnoides). The US National Poultry Research Center Institutional Animal Care and Use Committee reviewed and approved all procedures involving animals; the Institutional Biosafety Committee approved the use of the viruses. To evaluate their susceptibility to these viruses, 10 birds of each species were challenged with a virus isolate obtained from the Biodefense and Emerging Infections Research Resources Repository (BEI Resources; National Institute of Allergy and Infectious Diseases, National Institutes of Health). We used either the USA-WA1/2020 isolate of SARS-CoV-2 (BEI NR-58221) or the Florida/USA-2_SaudiArabia_2014 isolate of MERS-CoV (BEI NR-50415) (Appendix). We collected oropharyngeal and cloacal swabs from all birds at 2, 4, and 7 days postchallenge (dpc) and tested them for virus by real-time reverse transcription PCR. At 14 dpc we collected serum specimens from the birds and tested for antibody to the challenge virus by microneutralization. No clinical signs were observed at any time in any species, and virus was not detected in any swab material (Table). Antibodies were not detected in serum from any birds at 14 dpc. These results suggest that neither virus replicated in any of the avian species evaluated or that they replicated at a level that was too low to be detected.
Table

Poultry testing positive for SARS-CoV-2 or MERS-CoV, United States*

Species
SARS-COV-2

MERS-CoV
No. positive at 2 dpc

No. positive at 4 dpc

No. positive at 7 dpc

No. positive at 2 dpc

No. positive at 4 dpc

No. positive at 7 dpc

OP
CL
OP
CL
OP
CL
Antibody
OP
CL
OP
CL
OP
CL
Antibody
Chickens (Gallus gallus domesticus)00000000000000
Turkeys (Meleagris gallopavo)00000000000000
Japanese quail (Coturnix japonica)00000000000000
Pekin ducks (Anas platyrhinchos)00000000000000
Chinese domestic geese (Anser cygnoides)00000000000000

*Real-time reverse transcription PCR was used to test the oropharyngeal and cloacal swabs collected from 10 individuals of each poultry species inoculated with SARS-CoV-2 or MERS-CoV. We tested serum samples for antibody 14 dpc by virus neutralization assay. Three birds of each species served as noninoculated controls. CL, cloacal swab; dpc, days postchallenge; MERS-CoV, Middle East respiratory syndrome coronavirus; OP, oropharyngeal swab; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.

*Real-time reverse transcription PCR was used to test the oropharyngeal and cloacal swabs collected from 10 individuals of each poultry species inoculated with SARS-CoV-2 or MERS-CoV. We tested serum samples for antibody 14 dpc by virus neutralization assay. Three birds of each species served as noninoculated controls. CL, cloacal swab; dpc, days postchallenge; MERS-CoV, Middle East respiratory syndrome coronavirus; OP, oropharyngeal swab; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2. We tested ECE for their ability to support SARS-CoV-2 or MERS-CoV replication after inoculation with any of the 3 most common routes: yolk sac, chorioallantoic sac, or chorioallantoic membrane (Appendix). We collected yolk, allantoic fluid (albumin), and embryo tissues from inoculated eggs; we tested for viral replication by attempting virus isolation in Vero cells from the egg material after each of 2 ECE passages. We did not recover either virus in Vero cells from the inoculated ECEs, nor did we observe lesions in any of the embryos inoculated with SARS-CoV-2 or MERS-CoV. The ECE results with SARS-CoV-2 are consistent with the results reported by Barr et al. (). Identifying potential reservoir hosts of the novel coronaviruses is critical to controlling exposure and subsequent infection, as well as to preserving a safe and consistent food supply. None of the avian species nor the ECE appeared to support replication of either virus. Our findings demonstrate that poultry are unlikely to serve a role in the maintenance or transmission of either SARS-CoV-2 or MERS-CoV, and furthermore that ECE are not a viable laboratory host system.

Appendix

Additional information about susceptibility of poultry to SARS-CoV-2 and MERS-CoV.
  9 in total

1.  SARS-CoV-2 in fruit bats, ferrets, pigs, and chickens: an experimental transmission study.

Authors:  Kore Schlottau; Melanie Rissmann; Annika Graaf; Jacob Schön; Julia Sehl; Claudia Wylezich; Dirk Höper; Thomas C Mettenleiter; Anne Balkema-Buschmann; Timm Harder; Christian Grund; Donata Hoffmann; Angele Breithaupt; Martin Beer
Journal:  Lancet Microbe       Date:  2020-07-07

2.  Middle East Respiratory Syndrome (MERS) coronavirus seroprevalence in domestic livestock in Saudi Arabia, 2010 to 2013.

Authors:  M G Hemida; R A Perera; P Wang; M A Alhammadi; L Y Siu; M Li; L L Poon; L Saif; A Alnaeem; M Peiris
Journal:  Euro Surveill       Date:  2013-12-12

3.  Middle East respiratory syndrome coronavirus infection in non-camelid domestic mammals.

Authors:  Ahmed Kandeil; Mokhtar Gomaa; Mahmoud Shehata; Ahmed El-Taweel; Ahmed E Kayed; Awatef Abiadh; Jamel Jrijer; Yassmin Moatasim; Omnia Kutkat; Ola Bagato; Sara Mahmoud; Ahmed Mostafa; Rabeh El-Shesheny; Ranawaka Apm Perera; Ronald Lw Ko; Nagla Hassan; Basma Elsokary; Lotfi Allal; Ahmed Saad; Heba Sobhy; Pamela P McKenzie; Richard J Webby; Malik Peiris; Mohamed A Ali; Ghazi Kayali
Journal:  Emerg Microbes Infect       Date:  2019       Impact factor: 7.163

4.  MERS-CoV: a global challenge.

Authors: 
Journal:  Lancet       Date:  2013-06-08       Impact factor: 79.321

5.  Identification of MERS-CoV in dromedary camels.

Authors:  Neil M Ferguson; Maria D Van Kerkhove
Journal:  Lancet Infect Dis       Date:  2013-12-17       Impact factor: 25.071

6.  Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan.

Authors:  Jasper Fuk-Woo Chan; Kin-Hang Kok; Zheng Zhu; Hin Chu; Kelvin Kai-Wang To; Shuofeng Yuan; Kwok-Yung Yuen
Journal:  Emerg Microbes Infect       Date:  2020-01-28       Impact factor: 7.163

7.  Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2.

Authors:  Jianzhong Shi; Zhiyuan Wen; Gongxun Zhong; Huanliang Yang; Chong Wang; Baoying Huang; Renqiang Liu; Xijun He; Lei Shuai; Ziruo Sun; Yubo Zhao; Peipei Liu; Libin Liang; Pengfei Cui; Jinliang Wang; Xianfeng Zhang; Yuntao Guan; Wenjie Tan; Guizhen Wu; Hualan Chen; Zhigao Bu
Journal:  Science       Date:  2020-04-08       Impact factor: 47.728

Review 8.  Hosts and Sources of Endemic Human Coronaviruses.

Authors:  Victor M Corman; Doreen Muth; Daniela Niemeyer; Christian Drosten
Journal:  Adv Virus Res       Date:  2018-02-16       Impact factor: 9.937

9.  SARS-CoV-2 does not replicate in embryonated hen's eggs or in MDCK cell lines.

Authors:  Ian G Barr; Cleve Rynehart; Paul Whitney; Julian Druce
Journal:  Euro Surveill       Date:  2020-06
  9 in total
  33 in total

Review 1.  SARS-CoV-2 Infections in Animals: Reservoirs for Reverse Zoonosis and Models for Study.

Authors:  Tessa Prince; Shirley L Smith; Alan D Radford; Tom Solomon; Grant L Hughes; Edward I Patterson
Journal:  Viruses       Date:  2021-03-17       Impact factor: 5.048

2.  Aerosol-jet-printed graphene electrochemical immunosensors for rapid and label-free detection of SARS-CoV-2 in saliva.

Authors:  Cícero C Pola; Sonal V Rangnekar; Robert Sheets; Beata M Szydlowska; Julia R Downing; Kshama W Parate; Shay G Wallace; Daphne Tsai; Mark C Hersam; Carmen L Gomes; Jonathan C Claussen
Journal:  2d Mater       Date:  2022-06-10       Impact factor: 6.861

Review 3.  Natural and Experimental SARS-CoV-2 Infection in Domestic and Wild Animals.

Authors:  David A Meekins; Natasha N Gaudreault; Juergen A Richt
Journal:  Viruses       Date:  2021-10-04       Impact factor: 5.048

4.  Risk of human-to-wildlife transmission of SARS-CoV-2.

Authors:  Sophie Gryseels; Luc De Bruyn; Ralf Gyselings; Sébastien Calvignac-Spencer; Fabian H Leendertz; Herwig Leirs
Journal:  Mamm Rev       Date:  2020-10-06       Impact factor: 5.373

Review 5.  Bats, pangolins, minks and other animals - villains or victims of SARS-CoV-2?

Authors:  Beatriz do Vale; Ana Patrícia Lopes; Maria da Conceição Fontes; Mário Silvestre; Luís Cardoso; Ana Cláudia Coelho
Journal:  Vet Res Commun       Date:  2021-01-19       Impact factor: 2.459

6.  Intranasal Infection of Ferrets with SARS-CoV-2 as a Model for Asymptomatic Human Infection.

Authors:  Helen E Everett; Fabian Z X Lean; Alexander M P Byrne; Pauline M van Diemen; Shelley Rhodes; Joe James; Benjamin Mollett; Vivien J Coward; Paul Skinner; Caroline J Warren; Kevin R Bewley; Samantha Watson; Shellene Hurley; Kathryn A Ryan; Yper Hall; Hugh Simmons; Alejandro Núñez; Miles W Carroll; Ian H Brown; Sharon M Brookes
Journal:  Viruses       Date:  2021-01-15       Impact factor: 5.048

7.  First Description of SARS-CoV-2 Infection in Two Feral American Mink (Neovison vison) Caught in the Wild.

Authors:  Jordi Aguiló-Gisbert; Miguel Padilla-Blanco; Victor Lizana; Elisa Maiques; Marta Muñoz-Baquero; Eva Chillida-Martínez; Jesús Cardells; Consuelo Rubio-Guerri
Journal:  Animals (Basel)       Date:  2021-05-16       Impact factor: 2.752

Review 8.  [Avian coronaviroses: Characteristics of epidemiological interest, in comparative medicine].

Authors:  Moncef Bouzouaya
Journal:  Bull Acad Natl Med       Date:  2021-05-29       Impact factor: 0.144

9.  Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans.

Authors:  Bas B Oude Munnink; Reina S Sikkema; David F Nieuwenhuijse; Robert Jan Molenaar; Emmanuelle Munger; Richard Molenkamp; Arco van der Spek; Paulien Tolsma; Ariene Rietveld; Miranda Brouwer; Noortje Bouwmeester-Vincken; Frank Harders; Renate Hakze-van der Honing; Marjolein C A Wegdam-Blans; Ruth J Bouwstra; Corine GeurtsvanKessel; Annemiek A van der Eijk; Francisca C Velkers; Lidwien A M Smit; Arjan Stegeman; Wim H M van der Poel; Marion P G Koopmans
Journal:  Science       Date:  2020-11-10       Impact factor: 47.728

10.  Further information on possible animal sources for human COVID-19.

Authors:  Tanja Opriessnig; Yao-Wei Huang
Journal:  Xenotransplantation       Date:  2020-09-25       Impact factor: 3.788

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.